Abstract
The efficacy of a selective fusimotor suppressant, the phenothiazine (+/-)-10-3-dimethylamino-2-methylpropyl)-2-valeroylphenothiazine, has been assessed in a double-blind crossover trail in eight patients suffering from cerebral spasticity and one patient suffering from spinal spasticity. Dosage was 40 mg daily. Independent clinical and electromyographic methods of assessment were used. The active agent produced a small but significant reduction in spasticity, although this was of clinical value in only a few patients. There were few side-effects. It is recommended that further studies using higher dosages be undertaken.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ashby P., Burke D., Rao S., Jones R. F. Assessment of cyclobenzaprine in the treatment of spasticity. J Neurol Neurosurg Psychiatry. 1972 Oct;35(5):599–605. doi: 10.1136/jnnp.35.5.599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gilman S., Lieberman J. S., Marco L. A. Spinal mechanisms underlying the effects of unilateral ablation of areas 4 and 6 in monkeys. Brain. 1974 Mar;97(1):49–64. doi: 10.1093/brain/97.1.49. [DOI] [PubMed] [Google Scholar]
- Griffiths M. I., Bowie E. M. The use of dimethothiazine in the treatment of childhood cerebral palsy. Dev Med Child Neurol. 1973 Feb;15(1):25–32. doi: 10.1111/j.1469-8749.1973.tb04862.x. [DOI] [PubMed] [Google Scholar]
- HENATSCH H. D., INGVAR D. H. Chlorpromazin und Spastizität; eine experimentelle elektrophysiologische Untersuchung. Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr. 1956;195(1):77–93. doi: 10.1007/BF00342008. [DOI] [PubMed] [Google Scholar]
- Hagbarth K. E., Wallin G., Löfstedt L. Muscle spindle responses to stretch in normal and spastic subjects. Scand J Rehabil Med. 1973;5(4):156–159. [PubMed] [Google Scholar]
- Jones R. F., Burke D., Marosszeky J. E., Gillies J. D. A new agent for the control of spasticity. J Neurol Neurosurg Psychiatry. 1970 Aug;33(4):464–468. doi: 10.1136/jnnp.33.4.464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Keary E. M., Maxwell D. R. A comparison of the effects of chlorpromazine and some related phenothiazines in reducing the rigidity of the decerebrate cat and in some other central actions. Br J Pharmacol Chemother. 1967 Jun;30(2):400–416. doi: 10.1111/j.1476-5381.1967.tb02147.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Matthews W. B., Rushworth G., Wakefield G. S. Dimethothiazine in spasticity. A further attempt at pharmacological control. Acta Neurol Scand. 1972;48(5):635–644. doi: 10.1111/j.1600-0404.1972.tb07580.x. [DOI] [PubMed] [Google Scholar]
- Maxwell D. R., Read M. A., Sumpter E. A. Pharmacology of M & B 18,706, a drug which selectively reduces decerebrate rigidity. Br J Pharmacol. 1974 Jan;50(1):35–45. doi: 10.1111/j.1476-5381.1974.tb09590.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maxwell D. R., Rhodes K. F. Studies of the effects of dimethothiazine on muscle spindle activity in the decerebrate cat. J Physiol. 1970 May;208(1):29P–30P. [PubMed] [Google Scholar]
- Maxwell D. R., Sumpter E. A. A comparison of the actions of some drugs on decerebrate rigidity, muscle spindle activity and alpha-adrenoceptors. Br J Pharmacol. 1974 Mar;50(3):355–363. doi: 10.1111/j.1476-5381.1974.tb09610.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maxwell D. R., Sumpter E. A. Noradrenergic receptors and the control of fusimotor activity. J Physiol. 1972 Apr;222(2):173P–175P. [PubMed] [Google Scholar]
- RUSHWORTH G. Spasticity and rigidity: an experimental study and review. J Neurol Neurosurg Psychiatry. 1960 May;23:99–118. doi: 10.1136/jnnp.23.2.99. [DOI] [PMC free article] [PubMed] [Google Scholar]